The risk factors including having SLE or BD, taking AZA within the past two years, exposing to long-term medium to high dosage of glucocorticoids and having evidence of previous TB should be considered in the individualized clinical assessment of the risk of ATB in patients with rheumatic diseases not taking anti-TNF medications. This evidence concerns the gene TNF and rheumatic disorder.